Health Sciences Authority

Home > News > HSA Updates > 2009

HSA Updates - 2009

9 November 2009

HSA Requests Singapore Pharmaceutical Pte Ltd to Suspend Dextropropoxyphene Sales (Dolpoxene®, Dolpocetmol®)

Download pdf version here

File Size: (81 Kb)

9 September 2009

HSA Develops Educational Toolkit to Help Retailers Avoid Selling Tobacco Products to Underage Youth

Download pdf version here

File Size: (328 Kb)

6 August 2009

HSA Updates on Neuropsychiatric Adverse Events Suspected to be Associated with Oseltamivir (Tamiflu®)

Download pdf version here

File Size: (180 Kb)

24 July 2009

HSA Cigarette Testing Laboratory Designated a World Health Organisation Collaborating Centre for Tobacco Testing and Research

Download pdf version here

File Size: (172 Kb)

7 July 2009

Update No. 4 on Influenza A (H1N1-2009) Donor Deferral Guidelines

Download pdf version here

File Size: (129 Kb)

3 July 2009

HSA Pharmaceutical Laboratory Designated a World Health Organisation Prequalified Quality Control Laboratory in Pharmaceuticals

Download pdf version here

File Size: (88 Kb)

15 May 2009

Update No.3 on Influenza A (H1N1-2009) Donor Deferral Guidelines

Download pdf version here

File Size: (228 Kb)

4 May 2009

HSA Warns Against the Use of Hydroxycut Products

Download pdf version here

File Size: (221 Kb)

Update No.2 on Influenza A (H1N1-2009) Donor Deferral Guidelines

Download pdf version here

File Size: (241 Kb)

28 April 2009

Update No.1 on Influenza A (H1N1-2009) Donor Deferral Guidelines

Download pdf version here

File Size: (57 Kb)

4 March 2009

HSA Achieved ASHI Accreditation in Tissue Typing

Download pdf version here

File Size: (110 Kb)

26 February 2009

HSA Requests Merck to Suspend the Sales of Efalizumab (Raptiva®)

Download pdf version here

File Size: (117 Kb)

Last updated on 02 Jul 2010 16:25:41